Corcept Therapeutics Inc (NASDAQ: CORT) is 66.32% higher on its value in year-to-date trading and has touched a low of $20.84 and a high of $117.33 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CORT stock was last observed hovering at around $91.93 in the last trading session, with the day’s loss setting it -8.12%.
Currently trading at $83.81, the stock is 33.86% and 31.16% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.04 million and changing -8.83% at the moment leaves the stock 71.78% off its SMA200. CORT registered 225.60% gain for a year compared to 6-month gain of 81.09%. The firm has a 50-day simple moving average (SMA 50) of $63.9008 and a 200-day simple moving average (SMA200) of $48.78795.
The stock witnessed a 49.69% loss in the last 1 month and extending the period to 3 months gives it a 64.82%, and is 46.75% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 15.60% over the week and 7.36% over the month.
Corcept Therapeutics Inc (CORT) has around 500 employees, a market worth around $8.84B and $675.04M in sales. Current P/E ratio is 67.97 and Fwd P/E is 25.11. Profit margin for the company is 20.70%. Distance from 52-week low is 302.16% and -28.57% from its 52-week high. The company has generated returns on investments over the last 12 months (20.38%).
The EPS is expected to grow by 37.80% this year
491.0 institutions hold shares in Corcept Therapeutics Inc (CORT), with institutional investors hold 91.82% of the company’s shares. The shares outstanding are 105.11M, and float is at 93.19M with Short Float at 17.52%. Institutions hold 81.32% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 16.54 million shares valued at $537.36 million. The investor’s holdings represent 16.0391 of the CORT Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 9.55 million shares valued at $310.4 million to account for 9.2943 of the shares outstanding. The other top investors are INGALLS & SNYDER LLC which holds 8.24 million shares representing 7.989 and valued at over $267.66 million, while RENAISSANCE TECHNOLOGIES LLC holds 6.7036 of the shares totaling 6.91 million with a market value of $224.59 million.
Corcept Therapeutics Inc (CORT) Insider Activity
The most recent transaction is an insider sale by Maduck Sean,. SEC filings show that Maduck Sean sold 100,000 shares of the company’s common stock on Mar 31 ’25 at a price of $100.54 per share for a total of $10.05 million. Following the sale, the insider now owns 85622.0 shares.
Corcept Therapeutics Inc disclosed in a document filed with the SEC on Apr 01 ’25 that Maduck Sean sold a total of 590 shares of the company’s common stock. The trade occurred on Apr 01 ’25 and was made at $114.55 per share for $67584.0. Following the transaction, the insider now directly holds 85622.0 shares of the CORT stock.
Still, SEC filings show that on Mar 31 ’25, Lyon Joseph Douglas disposed off 200,000 shares at an average price of $100.47 for $20.09 million. The insider now directly holds 9,009 shares of Corcept Therapeutics Inc (CORT).
